Xujiang Yu

TL;DR: Ultraasmall Bi NPs (3.6 nm) were facilely synthesized using oleylamine as the reducing agent and exhibited a higher tumor accumulation after being conjugated with the tumor-homing peptide LyP-1 and shed light on the future use of semimetal nanoparticles for biomedicine.

TL;DR: The latest biomedical application including responsive MRI, multimodal imaging, nanozyme, MHT, photo-responsive therapy and drug delivery, the mechanism of corresponding treatments and cooperation therapies of multifunctional Fe3O4 NPs are explained.

TL;DR: It is demonstrated that a small quantity of PEGylated Cu3BiS3 NRs in tumors can concentrate radiation energy and trigger mild PTT under NIR-II irradiation and thus, these particles could be used as a novel, synergistic thermoradiotheraputic agent that enhances the efficacy of radiotherapy.

TL;DR: A way to tactfully understand and utilize nanoscintillators for cancer theranostics is shown, showing a higher tumor growth inhibition efficiency at a lower X-ray dose than radiotherapy alone.

TL;DR: The findings described are the first to demonstrate the existence of LSPR in non-stoichiometric silicon-based nanoparticles with a low-toxicity degradation pathway for in vivo application, and provide new insights towards understanding the role of new semiconductor nanoparticles in nanomedicine.